nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—ORM1—Erlotinib—pancreatic cancer	0.0873	0.119	CbGbCtD
Bupropion—CYP2A6—Tamoxifen—pancreatic cancer	0.0677	0.0923	CbGbCtD
Bupropion—CYP2E1—Dacarbazine—pancreatic cancer	0.0561	0.0766	CbGbCtD
Bupropion—CYP2A6—Fluorouracil—pancreatic cancer	0.0499	0.068	CbGbCtD
Bupropion—CYP2E1—Tamoxifen—pancreatic cancer	0.0447	0.0609	CbGbCtD
Bupropion—CYP2B6—Tamoxifen—pancreatic cancer	0.0441	0.0601	CbGbCtD
Bupropion—CYP2B6—Irinotecan—pancreatic cancer	0.0338	0.0462	CbGbCtD
Bupropion—CYP2C8—Tamoxifen—pancreatic cancer	0.0334	0.0455	CbGbCtD
Bupropion—CYP1A2—Dacarbazine—pancreatic cancer	0.0325	0.0443	CbGbCtD
Bupropion—CYP2C8—Erlotinib—pancreatic cancer	0.0284	0.0387	CbGbCtD
Bupropion—CYP1A2—Tamoxifen—pancreatic cancer	0.0258	0.0352	CbGbCtD
Bupropion—CYP2C8—Fluorouracil—pancreatic cancer	0.0246	0.0335	CbGbCtD
Bupropion—CYP2C9—Tamoxifen—pancreatic cancer	0.0233	0.0318	CbGbCtD
Bupropion—CYP1A2—Erlotinib—pancreatic cancer	0.022	0.03	CbGbCtD
Bupropion—CYP2D6—Tamoxifen—pancreatic cancer	0.0213	0.029	CbGbCtD
Bupropion—CYP1A2—Fluorouracil—pancreatic cancer	0.019	0.026	CbGbCtD
Bupropion—CYP2B6—Doxorubicin—pancreatic cancer	0.0185	0.0252	CbGbCtD
Bupropion—CYP2D6—Erlotinib—pancreatic cancer	0.0181	0.0247	CbGbCtD
Bupropion—CYP2C9—Fluorouracil—pancreatic cancer	0.0172	0.0234	CbGbCtD
Bupropion—CYP3A4—Tamoxifen—pancreatic cancer	0.0135	0.0185	CbGbCtD
Bupropion—CYP3A4—Erlotinib—pancreatic cancer	0.0115	0.0157	CbGbCtD
Bupropion—CYP3A4—Irinotecan—pancreatic cancer	0.0104	0.0142	CbGbCtD
Bupropion—CYP2D6—Doxorubicin—pancreatic cancer	0.00893	0.0122	CbGbCtD
Bupropion—CYP3A4—Docetaxel—pancreatic cancer	0.00762	0.0104	CbGbCtD
Bupropion—CYP3A4—Sunitinib—pancreatic cancer	0.00758	0.0103	CbGbCtD
Bupropion—CYP3A4—Doxorubicin—pancreatic cancer	0.00568	0.00775	CbGbCtD
Bupropion—Oedema—Docetaxel—pancreatic cancer	9.7e-05	0.000363	CcSEcCtD
Bupropion—Anaphylactic shock—Docetaxel—pancreatic cancer	9.7e-05	0.000363	CcSEcCtD
Bupropion—Weight increased—Doxorubicin—pancreatic cancer	9.69e-05	0.000363	CcSEcCtD
Bupropion—Epistaxis—Epirubicin—pancreatic cancer	9.68e-05	0.000362	CcSEcCtD
Bupropion—Pruritus—Gemcitabine—pancreatic cancer	9.67e-05	0.000362	CcSEcCtD
Bupropion—Infection—Docetaxel—pancreatic cancer	9.64e-05	0.000361	CcSEcCtD
Bupropion—Weight decreased—Doxorubicin—pancreatic cancer	9.63e-05	0.000361	CcSEcCtD
Bupropion—Sinusitis—Epirubicin—pancreatic cancer	9.62e-05	0.000361	CcSEcCtD
Bupropion—Hyperglycaemia—Doxorubicin—pancreatic cancer	9.6e-05	0.00036	CcSEcCtD
Bupropion—Diarrhoea—Irinotecan—pancreatic cancer	9.6e-05	0.00036	CcSEcCtD
Bupropion—Pneumonia—Doxorubicin—pancreatic cancer	9.55e-05	0.000358	CcSEcCtD
Bupropion—Shock—Docetaxel—pancreatic cancer	9.54e-05	0.000358	CcSEcCtD
Bupropion—Nervous system disorder—Docetaxel—pancreatic cancer	9.51e-05	0.000356	CcSEcCtD
Bupropion—Pruritus—Fluorouracil—pancreatic cancer	9.51e-05	0.000356	CcSEcCtD
Bupropion—Thrombocytopenia—Docetaxel—pancreatic cancer	9.5e-05	0.000356	CcSEcCtD
Bupropion—Infestation NOS—Doxorubicin—pancreatic cancer	9.49e-05	0.000356	CcSEcCtD
Bupropion—Infestation—Doxorubicin—pancreatic cancer	9.49e-05	0.000356	CcSEcCtD
Bupropion—Tachycardia—Docetaxel—pancreatic cancer	9.47e-05	0.000355	CcSEcCtD
Bupropion—Skin disorder—Docetaxel—pancreatic cancer	9.42e-05	0.000353	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	9.41e-05	0.000353	CcSEcCtD
Bupropion—Diarrhoea—Gemcitabine—pancreatic cancer	9.35e-05	0.00035	CcSEcCtD
Bupropion—Neuropathy peripheral—Doxorubicin—pancreatic cancer	9.3e-05	0.000349	CcSEcCtD
Bupropion—Dizziness—Irinotecan—pancreatic cancer	9.28e-05	0.000348	CcSEcCtD
Bupropion—Haemoglobin—Epirubicin—pancreatic cancer	9.26e-05	0.000347	CcSEcCtD
Bupropion—Stomatitis—Doxorubicin—pancreatic cancer	9.25e-05	0.000347	CcSEcCtD
Bupropion—Jaundice—Doxorubicin—pancreatic cancer	9.25e-05	0.000347	CcSEcCtD
Bupropion—Anorexia—Docetaxel—pancreatic cancer	9.25e-05	0.000346	CcSEcCtD
Bupropion—Rhinitis—Epirubicin—pancreatic cancer	9.23e-05	0.000346	CcSEcCtD
Bupropion—Conjunctivitis—Doxorubicin—pancreatic cancer	9.23e-05	0.000346	CcSEcCtD
Bupropion—Urinary tract infection—Doxorubicin—pancreatic cancer	9.23e-05	0.000346	CcSEcCtD
Bupropion—Haemorrhage—Epirubicin—pancreatic cancer	9.21e-05	0.000345	CcSEcCtD
Bupropion—Hepatitis—Epirubicin—pancreatic cancer	9.21e-05	0.000345	CcSEcCtD
Bupropion—Diarrhoea—Fluorouracil—pancreatic cancer	9.2e-05	0.000344	CcSEcCtD
Bupropion—Hypoaesthesia—Epirubicin—pancreatic cancer	9.16e-05	0.000343	CcSEcCtD
Bupropion—Pharyngitis—Epirubicin—pancreatic cancer	9.14e-05	0.000342	CcSEcCtD
Bupropion—Sweating—Doxorubicin—pancreatic cancer	9.1e-05	0.000341	CcSEcCtD
Bupropion—Urinary tract disorder—Epirubicin—pancreatic cancer	9.09e-05	0.000341	CcSEcCtD
Bupropion—Oedema peripheral—Epirubicin—pancreatic cancer	9.07e-05	0.00034	CcSEcCtD
Bupropion—Hypotension—Docetaxel—pancreatic cancer	9.06e-05	0.00034	CcSEcCtD
Bupropion—Connective tissue disorder—Epirubicin—pancreatic cancer	9.05e-05	0.000339	CcSEcCtD
Bupropion—Urethral disorder—Epirubicin—pancreatic cancer	9.03e-05	0.000338	CcSEcCtD
Bupropion—Epistaxis—Doxorubicin—pancreatic cancer	8.95e-05	0.000335	CcSEcCtD
Bupropion—Vomiting—Irinotecan—pancreatic cancer	8.92e-05	0.000334	CcSEcCtD
Bupropion—Sinusitis—Doxorubicin—pancreatic cancer	8.9e-05	0.000334	CcSEcCtD
Bupropion—Dizziness—Fluorouracil—pancreatic cancer	8.89e-05	0.000333	CcSEcCtD
Bupropion—Visual impairment—Epirubicin—pancreatic cancer	8.87e-05	0.000332	CcSEcCtD
Bupropion—Rash—Irinotecan—pancreatic cancer	8.85e-05	0.000331	CcSEcCtD
Bupropion—Dermatitis—Irinotecan—pancreatic cancer	8.84e-05	0.000331	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	8.84e-05	0.000331	CcSEcCtD
Bupropion—Headache—Irinotecan—pancreatic cancer	8.79e-05	0.000329	CcSEcCtD
Bupropion—Insomnia—Docetaxel—pancreatic cancer	8.77e-05	0.000329	CcSEcCtD
Bupropion—Paraesthesia—Docetaxel—pancreatic cancer	8.71e-05	0.000326	CcSEcCtD
Bupropion—Erythema multiforme—Epirubicin—pancreatic cancer	8.71e-05	0.000326	CcSEcCtD
Bupropion—Vomiting—Gemcitabine—pancreatic cancer	8.69e-05	0.000326	CcSEcCtD
Bupropion—Dyspnoea—Docetaxel—pancreatic cancer	8.65e-05	0.000324	CcSEcCtD
Bupropion—Somnolence—Docetaxel—pancreatic cancer	8.62e-05	0.000323	CcSEcCtD
Bupropion—Rash—Gemcitabine—pancreatic cancer	8.62e-05	0.000323	CcSEcCtD
Bupropion—Dermatitis—Gemcitabine—pancreatic cancer	8.61e-05	0.000323	CcSEcCtD
Bupropion—Eye disorder—Epirubicin—pancreatic cancer	8.61e-05	0.000322	CcSEcCtD
Bupropion—Tinnitus—Epirubicin—pancreatic cancer	8.59e-05	0.000322	CcSEcCtD
Bupropion—Haemoglobin—Doxorubicin—pancreatic cancer	8.56e-05	0.000321	CcSEcCtD
Bupropion—Headache—Gemcitabine—pancreatic cancer	8.56e-05	0.000321	CcSEcCtD
Bupropion—Flushing—Epirubicin—pancreatic cancer	8.55e-05	0.00032	CcSEcCtD
Bupropion—Cardiac disorder—Epirubicin—pancreatic cancer	8.55e-05	0.00032	CcSEcCtD
Bupropion—Vomiting—Fluorouracil—pancreatic cancer	8.54e-05	0.00032	CcSEcCtD
Bupropion—Rhinitis—Doxorubicin—pancreatic cancer	8.54e-05	0.00032	CcSEcCtD
Bupropion—Dyspepsia—Docetaxel—pancreatic cancer	8.54e-05	0.00032	CcSEcCtD
Bupropion—Haemorrhage—Doxorubicin—pancreatic cancer	8.52e-05	0.000319	CcSEcCtD
Bupropion—Hepatitis—Doxorubicin—pancreatic cancer	8.52e-05	0.000319	CcSEcCtD
Bupropion—Hypoaesthesia—Doxorubicin—pancreatic cancer	8.48e-05	0.000318	CcSEcCtD
Bupropion—Rash—Fluorouracil—pancreatic cancer	8.47e-05	0.000317	CcSEcCtD
Bupropion—Dermatitis—Fluorouracil—pancreatic cancer	8.47e-05	0.000317	CcSEcCtD
Bupropion—Pharyngitis—Doxorubicin—pancreatic cancer	8.46e-05	0.000317	CcSEcCtD
Bupropion—Decreased appetite—Docetaxel—pancreatic cancer	8.43e-05	0.000316	CcSEcCtD
Bupropion—Headache—Fluorouracil—pancreatic cancer	8.42e-05	0.000315	CcSEcCtD
Bupropion—Urinary tract disorder—Doxorubicin—pancreatic cancer	8.41e-05	0.000315	CcSEcCtD
Bupropion—Oedema peripheral—Doxorubicin—pancreatic cancer	8.39e-05	0.000314	CcSEcCtD
Bupropion—Gastrointestinal disorder—Docetaxel—pancreatic cancer	8.37e-05	0.000314	CcSEcCtD
Bupropion—Connective tissue disorder—Doxorubicin—pancreatic cancer	8.37e-05	0.000314	CcSEcCtD
Bupropion—Fatigue—Docetaxel—pancreatic cancer	8.36e-05	0.000313	CcSEcCtD
Bupropion—Angiopathy—Epirubicin—pancreatic cancer	8.36e-05	0.000313	CcSEcCtD
Bupropion—Urethral disorder—Doxorubicin—pancreatic cancer	8.35e-05	0.000313	CcSEcCtD
Bupropion—Nausea—Irinotecan—pancreatic cancer	8.33e-05	0.000312	CcSEcCtD
Bupropion—Immune system disorder—Epirubicin—pancreatic cancer	8.32e-05	0.000312	CcSEcCtD
Bupropion—Mediastinal disorder—Epirubicin—pancreatic cancer	8.3e-05	0.000311	CcSEcCtD
Bupropion—Constipation—Docetaxel—pancreatic cancer	8.29e-05	0.000311	CcSEcCtD
Bupropion—Pain—Docetaxel—pancreatic cancer	8.29e-05	0.000311	CcSEcCtD
Bupropion—Chills—Epirubicin—pancreatic cancer	8.26e-05	0.00031	CcSEcCtD
Bupropion—Arrhythmia—Epirubicin—pancreatic cancer	8.23e-05	0.000308	CcSEcCtD
Bupropion—Visual impairment—Doxorubicin—pancreatic cancer	8.21e-05	0.000308	CcSEcCtD
Bupropion—Alopecia—Epirubicin—pancreatic cancer	8.14e-05	0.000305	CcSEcCtD
Bupropion—Nausea—Gemcitabine—pancreatic cancer	8.12e-05	0.000304	CcSEcCtD
Bupropion—Mental disorder—Epirubicin—pancreatic cancer	8.07e-05	0.000302	CcSEcCtD
Bupropion—Erythema multiforme—Doxorubicin—pancreatic cancer	8.06e-05	0.000302	CcSEcCtD
Bupropion—Malnutrition—Epirubicin—pancreatic cancer	8.02e-05	0.0003	CcSEcCtD
Bupropion—Feeling abnormal—Docetaxel—pancreatic cancer	7.99e-05	0.000299	CcSEcCtD
Bupropion—Nausea—Fluorouracil—pancreatic cancer	7.98e-05	0.000299	CcSEcCtD
Bupropion—Eye disorder—Doxorubicin—pancreatic cancer	7.96e-05	0.000298	CcSEcCtD
Bupropion—Tinnitus—Doxorubicin—pancreatic cancer	7.94e-05	0.000298	CcSEcCtD
Bupropion—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.93e-05	0.000297	CcSEcCtD
Bupropion—Flushing—Doxorubicin—pancreatic cancer	7.91e-05	0.000296	CcSEcCtD
Bupropion—Cardiac disorder—Doxorubicin—pancreatic cancer	7.91e-05	0.000296	CcSEcCtD
Bupropion—Flatulence—Epirubicin—pancreatic cancer	7.9e-05	0.000296	CcSEcCtD
Bupropion—Tension—Epirubicin—pancreatic cancer	7.87e-05	0.000295	CcSEcCtD
Bupropion—Dysgeusia—Epirubicin—pancreatic cancer	7.85e-05	0.000294	CcSEcCtD
Bupropion—Nervousness—Epirubicin—pancreatic cancer	7.79e-05	0.000292	CcSEcCtD
Bupropion—Back pain—Epirubicin—pancreatic cancer	7.75e-05	0.00029	CcSEcCtD
Bupropion—Angiopathy—Doxorubicin—pancreatic cancer	7.73e-05	0.00029	CcSEcCtD
Bupropion—Muscle spasms—Epirubicin—pancreatic cancer	7.71e-05	0.000289	CcSEcCtD
Bupropion—Immune system disorder—Doxorubicin—pancreatic cancer	7.7e-05	0.000288	CcSEcCtD
Bupropion—Mediastinal disorder—Doxorubicin—pancreatic cancer	7.68e-05	0.000288	CcSEcCtD
Bupropion—Abdominal pain—Docetaxel—pancreatic cancer	7.67e-05	0.000287	CcSEcCtD
Bupropion—Body temperature increased—Docetaxel—pancreatic cancer	7.67e-05	0.000287	CcSEcCtD
Bupropion—Chills—Doxorubicin—pancreatic cancer	7.65e-05	0.000286	CcSEcCtD
Bupropion—Arrhythmia—Doxorubicin—pancreatic cancer	7.61e-05	0.000285	CcSEcCtD
Bupropion—Vision blurred—Epirubicin—pancreatic cancer	7.55e-05	0.000283	CcSEcCtD
Bupropion—Alopecia—Doxorubicin—pancreatic cancer	7.53e-05	0.000282	CcSEcCtD
Bupropion—Mental disorder—Doxorubicin—pancreatic cancer	7.46e-05	0.00028	CcSEcCtD
Bupropion—Ill-defined disorder—Epirubicin—pancreatic cancer	7.44e-05	0.000279	CcSEcCtD
Bupropion—Malnutrition—Doxorubicin—pancreatic cancer	7.42e-05	0.000278	CcSEcCtD
Bupropion—Anaemia—Epirubicin—pancreatic cancer	7.41e-05	0.000278	CcSEcCtD
Bupropion—Agitation—Epirubicin—pancreatic cancer	7.37e-05	0.000276	CcSEcCtD
Bupropion—Flatulence—Doxorubicin—pancreatic cancer	7.31e-05	0.000274	CcSEcCtD
Bupropion—Tension—Doxorubicin—pancreatic cancer	7.28e-05	0.000273	CcSEcCtD
Bupropion—Dysgeusia—Doxorubicin—pancreatic cancer	7.26e-05	0.000272	CcSEcCtD
Bupropion—Malaise—Epirubicin—pancreatic cancer	7.23e-05	0.000271	CcSEcCtD
Bupropion—Nervousness—Doxorubicin—pancreatic cancer	7.2e-05	0.00027	CcSEcCtD
Bupropion—Vertigo—Epirubicin—pancreatic cancer	7.2e-05	0.00027	CcSEcCtD
Bupropion—Syncope—Epirubicin—pancreatic cancer	7.19e-05	0.000269	CcSEcCtD
Bupropion—Leukopenia—Epirubicin—pancreatic cancer	7.18e-05	0.000269	CcSEcCtD
Bupropion—Back pain—Doxorubicin—pancreatic cancer	7.17e-05	0.000269	CcSEcCtD
Bupropion—Hypersensitivity—Docetaxel—pancreatic cancer	7.15e-05	0.000268	CcSEcCtD
Bupropion—Muscle spasms—Doxorubicin—pancreatic cancer	7.13e-05	0.000267	CcSEcCtD
Bupropion—Palpitations—Epirubicin—pancreatic cancer	7.08e-05	0.000265	CcSEcCtD
Bupropion—Loss of consciousness—Epirubicin—pancreatic cancer	7.05e-05	0.000264	CcSEcCtD
Bupropion—Cough—Epirubicin—pancreatic cancer	7e-05	0.000262	CcSEcCtD
Bupropion—Vision blurred—Doxorubicin—pancreatic cancer	6.99e-05	0.000262	CcSEcCtD
Bupropion—Asthenia—Docetaxel—pancreatic cancer	6.96e-05	0.000261	CcSEcCtD
Bupropion—Convulsion—Epirubicin—pancreatic cancer	6.95e-05	0.00026	CcSEcCtD
Bupropion—Hypertension—Epirubicin—pancreatic cancer	6.92e-05	0.000259	CcSEcCtD
Bupropion—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.88e-05	0.000258	CcSEcCtD
Bupropion—Pruritus—Docetaxel—pancreatic cancer	6.86e-05	0.000257	CcSEcCtD
Bupropion—Anaemia—Doxorubicin—pancreatic cancer	6.86e-05	0.000257	CcSEcCtD
Bupropion—Myalgia—Epirubicin—pancreatic cancer	6.82e-05	0.000256	CcSEcCtD
Bupropion—Arthralgia—Epirubicin—pancreatic cancer	6.82e-05	0.000256	CcSEcCtD
Bupropion—Chest pain—Epirubicin—pancreatic cancer	6.82e-05	0.000256	CcSEcCtD
Bupropion—Agitation—Doxorubicin—pancreatic cancer	6.82e-05	0.000255	CcSEcCtD
Bupropion—Anxiety—Epirubicin—pancreatic cancer	6.8e-05	0.000255	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	6.78e-05	0.000254	CcSEcCtD
Bupropion—Discomfort—Epirubicin—pancreatic cancer	6.74e-05	0.000253	CcSEcCtD
Bupropion—Malaise—Doxorubicin—pancreatic cancer	6.69e-05	0.000251	CcSEcCtD
Bupropion—Dry mouth—Epirubicin—pancreatic cancer	6.67e-05	0.00025	CcSEcCtD
Bupropion—Vertigo—Doxorubicin—pancreatic cancer	6.66e-05	0.00025	CcSEcCtD
Bupropion—Syncope—Doxorubicin—pancreatic cancer	6.65e-05	0.000249	CcSEcCtD
Bupropion—Leukopenia—Doxorubicin—pancreatic cancer	6.64e-05	0.000249	CcSEcCtD
Bupropion—Diarrhoea—Docetaxel—pancreatic cancer	6.64e-05	0.000249	CcSEcCtD
Bupropion—Confusional state—Epirubicin—pancreatic cancer	6.6e-05	0.000247	CcSEcCtD
Bupropion—Palpitations—Doxorubicin—pancreatic cancer	6.55e-05	0.000246	CcSEcCtD
Bupropion—Anaphylactic shock—Epirubicin—pancreatic cancer	6.54e-05	0.000245	CcSEcCtD
Bupropion—Oedema—Epirubicin—pancreatic cancer	6.54e-05	0.000245	CcSEcCtD
Bupropion—Loss of consciousness—Doxorubicin—pancreatic cancer	6.52e-05	0.000244	CcSEcCtD
Bupropion—Infection—Epirubicin—pancreatic cancer	6.5e-05	0.000243	CcSEcCtD
Bupropion—Cough—Doxorubicin—pancreatic cancer	6.47e-05	0.000242	CcSEcCtD
Bupropion—Shock—Epirubicin—pancreatic cancer	6.44e-05	0.000241	CcSEcCtD
Bupropion—Convulsion—Doxorubicin—pancreatic cancer	6.43e-05	0.000241	CcSEcCtD
Bupropion—Nervous system disorder—Epirubicin—pancreatic cancer	6.42e-05	0.00024	CcSEcCtD
Bupropion—Dizziness—Docetaxel—pancreatic cancer	6.41e-05	0.00024	CcSEcCtD
Bupropion—Thrombocytopenia—Epirubicin—pancreatic cancer	6.41e-05	0.00024	CcSEcCtD
Bupropion—Hypertension—Doxorubicin—pancreatic cancer	6.4e-05	0.00024	CcSEcCtD
Bupropion—Tachycardia—Epirubicin—pancreatic cancer	6.39e-05	0.000239	CcSEcCtD
Bupropion—Skin disorder—Epirubicin—pancreatic cancer	6.35e-05	0.000238	CcSEcCtD
Bupropion—Hyperhidrosis—Epirubicin—pancreatic cancer	6.32e-05	0.000237	CcSEcCtD
Bupropion—Chest pain—Doxorubicin—pancreatic cancer	6.31e-05	0.000237	CcSEcCtD
Bupropion—Arthralgia—Doxorubicin—pancreatic cancer	6.31e-05	0.000237	CcSEcCtD
Bupropion—Myalgia—Doxorubicin—pancreatic cancer	6.31e-05	0.000237	CcSEcCtD
Bupropion—Anxiety—Doxorubicin—pancreatic cancer	6.29e-05	0.000236	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	6.27e-05	0.000235	CcSEcCtD
Bupropion—Discomfort—Doxorubicin—pancreatic cancer	6.24e-05	0.000234	CcSEcCtD
Bupropion—Anorexia—Epirubicin—pancreatic cancer	6.24e-05	0.000234	CcSEcCtD
Bupropion—Dry mouth—Doxorubicin—pancreatic cancer	6.18e-05	0.000231	CcSEcCtD
Bupropion—Vomiting—Docetaxel—pancreatic cancer	6.17e-05	0.000231	CcSEcCtD
Bupropion—Rash—Docetaxel—pancreatic cancer	6.12e-05	0.000229	CcSEcCtD
Bupropion—Hypotension—Epirubicin—pancreatic cancer	6.11e-05	0.000229	CcSEcCtD
Bupropion—Dermatitis—Docetaxel—pancreatic cancer	6.11e-05	0.000229	CcSEcCtD
Bupropion—Confusional state—Doxorubicin—pancreatic cancer	6.1e-05	0.000229	CcSEcCtD
Bupropion—Headache—Docetaxel—pancreatic cancer	6.08e-05	0.000228	CcSEcCtD
Bupropion—Oedema—Doxorubicin—pancreatic cancer	6.05e-05	0.000227	CcSEcCtD
Bupropion—Anaphylactic shock—Doxorubicin—pancreatic cancer	6.05e-05	0.000227	CcSEcCtD
Bupropion—Infection—Doxorubicin—pancreatic cancer	6.01e-05	0.000225	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.96e-05	0.000223	CcSEcCtD
Bupropion—Shock—Doxorubicin—pancreatic cancer	5.96e-05	0.000223	CcSEcCtD
Bupropion—Nervous system disorder—Doxorubicin—pancreatic cancer	5.94e-05	0.000222	CcSEcCtD
Bupropion—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.93e-05	0.000222	CcSEcCtD
Bupropion—Insomnia—Epirubicin—pancreatic cancer	5.92e-05	0.000222	CcSEcCtD
Bupropion—Tachycardia—Doxorubicin—pancreatic cancer	5.91e-05	0.000221	CcSEcCtD
Bupropion—Skin disorder—Doxorubicin—pancreatic cancer	5.88e-05	0.00022	CcSEcCtD
Bupropion—Paraesthesia—Epirubicin—pancreatic cancer	5.87e-05	0.00022	CcSEcCtD
Bupropion—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.85e-05	0.000219	CcSEcCtD
Bupropion—Dyspnoea—Epirubicin—pancreatic cancer	5.83e-05	0.000219	CcSEcCtD
Bupropion—Somnolence—Epirubicin—pancreatic cancer	5.82e-05	0.000218	CcSEcCtD
Bupropion—Anorexia—Doxorubicin—pancreatic cancer	5.77e-05	0.000216	CcSEcCtD
Bupropion—Nausea—Docetaxel—pancreatic cancer	5.76e-05	0.000216	CcSEcCtD
Bupropion—Dyspepsia—Epirubicin—pancreatic cancer	5.76e-05	0.000216	CcSEcCtD
Bupropion—Decreased appetite—Epirubicin—pancreatic cancer	5.69e-05	0.000213	CcSEcCtD
Bupropion—Hypotension—Doxorubicin—pancreatic cancer	5.66e-05	0.000212	CcSEcCtD
Bupropion—Gastrointestinal disorder—Epirubicin—pancreatic cancer	5.65e-05	0.000212	CcSEcCtD
Bupropion—Fatigue—Epirubicin—pancreatic cancer	5.64e-05	0.000211	CcSEcCtD
Bupropion—Constipation—Epirubicin—pancreatic cancer	5.59e-05	0.00021	CcSEcCtD
Bupropion—Pain—Epirubicin—pancreatic cancer	5.59e-05	0.00021	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.52e-05	0.000207	CcSEcCtD
Bupropion—Insomnia—Doxorubicin—pancreatic cancer	5.48e-05	0.000205	CcSEcCtD
Bupropion—Paraesthesia—Doxorubicin—pancreatic cancer	5.44e-05	0.000204	CcSEcCtD
Bupropion—Dyspnoea—Doxorubicin—pancreatic cancer	5.4e-05	0.000202	CcSEcCtD
Bupropion—Feeling abnormal—Epirubicin—pancreatic cancer	5.39e-05	0.000202	CcSEcCtD
Bupropion—Somnolence—Doxorubicin—pancreatic cancer	5.38e-05	0.000202	CcSEcCtD
Bupropion—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.35e-05	0.0002	CcSEcCtD
Bupropion—Dyspepsia—Doxorubicin—pancreatic cancer	5.33e-05	0.0002	CcSEcCtD
Bupropion—Decreased appetite—Doxorubicin—pancreatic cancer	5.26e-05	0.000197	CcSEcCtD
Bupropion—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	5.23e-05	0.000196	CcSEcCtD
Bupropion—Fatigue—Doxorubicin—pancreatic cancer	5.22e-05	0.000196	CcSEcCtD
Bupropion—Urticaria—Epirubicin—pancreatic cancer	5.2e-05	0.000195	CcSEcCtD
Bupropion—Pain—Doxorubicin—pancreatic cancer	5.18e-05	0.000194	CcSEcCtD
Bupropion—Constipation—Doxorubicin—pancreatic cancer	5.18e-05	0.000194	CcSEcCtD
Bupropion—Abdominal pain—Epirubicin—pancreatic cancer	5.17e-05	0.000194	CcSEcCtD
Bupropion—Body temperature increased—Epirubicin—pancreatic cancer	5.17e-05	0.000194	CcSEcCtD
Bupropion—Feeling abnormal—Doxorubicin—pancreatic cancer	4.99e-05	0.000187	CcSEcCtD
Bupropion—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.95e-05	0.000185	CcSEcCtD
Bupropion—Hypersensitivity—Epirubicin—pancreatic cancer	4.82e-05	0.000181	CcSEcCtD
Bupropion—Urticaria—Doxorubicin—pancreatic cancer	4.81e-05	0.00018	CcSEcCtD
Bupropion—Body temperature increased—Doxorubicin—pancreatic cancer	4.79e-05	0.000179	CcSEcCtD
Bupropion—Abdominal pain—Doxorubicin—pancreatic cancer	4.79e-05	0.000179	CcSEcCtD
Bupropion—Asthenia—Epirubicin—pancreatic cancer	4.69e-05	0.000176	CcSEcCtD
Bupropion—Pruritus—Epirubicin—pancreatic cancer	4.63e-05	0.000173	CcSEcCtD
Bupropion—Diarrhoea—Epirubicin—pancreatic cancer	4.48e-05	0.000168	CcSEcCtD
Bupropion—Hypersensitivity—Doxorubicin—pancreatic cancer	4.46e-05	0.000167	CcSEcCtD
Bupropion—Asthenia—Doxorubicin—pancreatic cancer	4.34e-05	0.000163	CcSEcCtD
Bupropion—Dizziness—Epirubicin—pancreatic cancer	4.33e-05	0.000162	CcSEcCtD
Bupropion—Pruritus—Doxorubicin—pancreatic cancer	4.28e-05	0.00016	CcSEcCtD
Bupropion—Vomiting—Epirubicin—pancreatic cancer	4.16e-05	0.000156	CcSEcCtD
Bupropion—Diarrhoea—Doxorubicin—pancreatic cancer	4.14e-05	0.000155	CcSEcCtD
Bupropion—Rash—Epirubicin—pancreatic cancer	4.13e-05	0.000155	CcSEcCtD
Bupropion—Dermatitis—Epirubicin—pancreatic cancer	4.12e-05	0.000154	CcSEcCtD
Bupropion—Headache—Epirubicin—pancreatic cancer	4.1e-05	0.000154	CcSEcCtD
Bupropion—Dizziness—Doxorubicin—pancreatic cancer	4e-05	0.00015	CcSEcCtD
Bupropion—Nausea—Epirubicin—pancreatic cancer	3.89e-05	0.000146	CcSEcCtD
Bupropion—Vomiting—Doxorubicin—pancreatic cancer	3.85e-05	0.000144	CcSEcCtD
Bupropion—Rash—Doxorubicin—pancreatic cancer	3.82e-05	0.000143	CcSEcCtD
Bupropion—Dermatitis—Doxorubicin—pancreatic cancer	3.81e-05	0.000143	CcSEcCtD
Bupropion—Headache—Doxorubicin—pancreatic cancer	3.79e-05	0.000142	CcSEcCtD
Bupropion—Nausea—Doxorubicin—pancreatic cancer	3.6e-05	0.000135	CcSEcCtD
